Aroa Biosurgery Limited
AROAF
$0.40
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.05% | 24.71% | -1.39% | 31.56% | 2.16% |
| Total Depreciation and Amortization | -- | -- | 1.39% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.05% | -117.88% | 1.39% | 973.19% | 2.15% |
| Change in Net Operating Assets | -- | -- | -1.39% | -- | -- |
| Cash from Operations | -1.05% | -6,388.99% | -1.34% | 98.99% | 2.17% |
| Capital Expenditure | -1.06% | -9.48% | -1.38% | 33.21% | 2.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.05% | -3.78% | 1.39% | 137.39% | -2.17% |
| Cash from Investing | 1.05% | -6.06% | 1.39% | 323.33% | -2.17% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -38.59% | 0.00% | 7.79% | 0.00% |
| Issuance of Common Stock | 0.00% | -69.81% | 0.00% | -8.62% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -39.20% | 0.00% | 23.14% | 0.00% |
| Cash from Financing | -1.05% | -48.98% | -1.39% | 14.15% | 2.15% |
| Foreign Exchange rate Adjustments | -0.94% | -49.82% | -1.42% | -127.74% | -2.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.05% | -72.87% | 1.39% | 235.28% | 2.17% |
